Evidence map›Paper›PMID 41082228›Full record

ArticleJAMA network open2025

Survival Determinants and Sociodemographic Disparities in Early-Onset Non-Small Cell Lung Cancer.

Irem Kar, Farheen Vhora, Maroun Bou Zerdan, Kubra Canaslan, Dhiksha Balaji, Badi El Osta, Sweta Balaji, Katie O'Reilly, Ticiana Leal, Tarun Jain and 5 more

Abstract read
In one paragraph

Article in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Irem KarDepartment of Biomedical Informatics, Emory University, Atlanta, Georgia.
Farheen VhoraDepartment of Medicine, B. J. Medical College, Ahmedabad, India.
Maroun Bou ZerdanWinship Cancer Institute, Department of Hematology and Oncology, Emory School of Medicine, Atlanta, Georgia.
Kubra CanaslanDepartment of Medical Oncology, Dokuz Eylul University, Izmir, Türkiye.
Dhiksha BalajiWinship Cancer Institute, Department of Hematology and Oncology, Emory School of Medicine, Atlanta, Georgia.
Badi El OstaWinship Cancer Institute, Department of Hematology and Oncology, Emory School of Medicine, Atlanta, Georgia.
Sweta BalajiDepartment of Biomedical Informatics, Emory University, Atlanta, Georgia.
Katie O'ReillyWinship Cancer Institute, Department of Hematology and Oncology, Emory School of Medicine, Atlanta, Georgia.
Ticiana LealWinship Cancer Institute, Department of Hematology and Oncology, Emory School of Medicine, Atlanta, Georgia.
Tarun JainWinship Cancer Institute, Department of Hematology and Oncology, Emory School of Medicine, Atlanta, Georgia.
Suresh RamalingamWinship Cancer Institute, Department of Hematology and Oncology, Emory School of Medicine, Atlanta, Georgia.
Conor E SteuerWinship Cancer Institute, Department of Hematology and Oncology, Emory School of Medicine, Atlanta, Georgia.
Jennifer W CarlisleWinship Cancer Institute, Department of Hematology and Oncology, Emory School of Medicine, Atlanta, Georgia.
Selen BozkurtDepartment of Biomedical Informatics, Emory University, Atlanta, Georgia.
Fatemeh Ardeshir-LarijaniWinship Cancer Institute, Department of Hematology and Oncology, Emory School of Medicine, Atlanta, Georgia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Patients with early-onset non-small cell lung cancer (NSCLC) represent a distinct and relatively understudied population. Identifying factors associated with survival is critical to guiding early detection and treatment strategies. Objective: To evaluate demographic, clinical, and socioeconomic factors associated with overall survival (OS) in early-onset NSCLC. Design, Setting, and Participants: This retrospective cohort study obtained data from the Surveillance, Epidemiology, and End Results database and included patients aged 18 to 50 years diagnosed with NSCLC between January 2010 and December 2021. Data analysis was performed between January 1 and March 31, 2025. Exposure: Early-onset NSCLC. Main Outcomes and Measures: The primary outcome was OS. Cox proportional hazards regression and Shapley additive explanations-enhanced machine learning models were used to improve interpretability and inform targeted interventions. Random survival forest models were used to identify factors associated with OS and assess model performance. Results: Among 18 595 patients with early-onset NSCLC, 9929 (53.4%) presented with stage IV disease. Most patients (15 597 [83.9%]) were aged 40 to 50 years (mean [SD] age, 44.6 [6.0] years), and 9710 (52.2%) were female. In terms of race and ethnicity, 2338 patients (12.6%) were Hispanic; 100 (0.5%), American Indian or Alaska Native; 2229 (12.0%), non-Hispanic Asian or Pacific Islander; 2693 (14.5%), non-Hispanic Black; 11 162 (60.0%) non-Hispanic White; and 73 (0.4%), unknown. In multivariable Cox proportional hazards regression, stage IV disease (hazard ratio [HR], 17.47; 95% CI, 15.28-19.96), liver metastases (HR, 1.45; 95% CI, 1.35-1.54), low household income (HR, 1.45; 95% CI, 1.33-1.58), squamous cell carcinoma histology (HR, 1.42; 95% CI, 1.33-1.51), and male sex (HR, 1.19; 95% CI, 1.14-1.25) were independently associated with worse survival. The random survival forest model demonstrated higher discrimination (C-index 0.765; 95% CI, 0.759-0.771), comparable to the Cox proportional hazards model (C-index, 0.774; 95% CI, 0.769-0.779). Feature importance analysis identified overall stage, radiation therapy, time to treatment, and household income as the most influential factors associated with survival. Among patients with stage I disease, rural residence was associated with a 65% increased risk of death (HR, 1.65; 95% CI, 1.23-2.08) and low household income was associated with a 96% increased risk of death (HR, 1.96; 95% CI, 1.52-2.55). Conclusions and Relevance: In this cohort study of 18 595 patients with early-onset NSCLC, most patients were diagnosed at advanced stages. Modifiable factors, including household income, residence, and time to treatment, were associated with survival outcomes. These findings support the need for increased awareness, early detection strategies, and efforts to reduce socioeconomic disparities in adults with NSCLC.

Indexed as

Carcinoma, Non-Small-Cell LungHealth Status DisparitiesLung NeoplasmsAdolescentAdultAge of OnsetFemaleHumansMaleMiddle AgedProportional Hazards ModelsRetrospective StudiesSEER ProgramSocioeconomic FactorsUnited StatesYoung Adult

Identifiers

PMID41082228
PMCPMC12519311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.